191
Participants
Start Date
September 28, 2021
Primary Completion Date
December 10, 2024
Study Completion Date
December 10, 2024
Pembrolizumab/vibostolimab coformuation
Pembrolizumab 200 mg + vibostolimab 200 mg/20 mL vial IV infusion Q3W up to approximately 2 years.
Chang Gung Medical Foundation-Linkou Branch ( Site 0262), Taoyuan District
Semmelweis University-Belgyógyászati és Hematológiai Klinika ( Site 0403), Budapest
Országos Onkológiai Intézet-HEMATOLÓGIA ÉS LYMPHOMA OSZTÁLY KEMOTERÁPIA A ( Site 0405), Budapest
Rigshospitalet-Hematology - CTU ( Site 0361), Copenhagen
Debreceni Egyetem Klinikai Kozpont-Belgyógyászati Klinika (Haematologia) ( Site 0402), Debrecen
Pécsi Tudományegyetem Klinikai Központ-I.sz. Belgyógyászati Klinika Hematológia ( Site 0401), Pécs
Aarhus Universitetshospital, Skejby-Blodsygdomme ( Site 0362), Aarhus
Cherkasy Regional Oncology Dispensary ( Site 0593), Cherkassy
Ospedale San Raffaele-Unità Linfomi ( Site 0382), Milan
Universitaetsklinikum Hamburg-Eppendorf-II. medical clinic ( Site 0332), Hamburg
Azienda Ospedaliera Spedali Civili di Brescia-Hemathology ( Site 0400), Brescia
Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 0446), Madrid
Clinica Universidad de Navarra ( Site 0444), Pamplona
Mega Medipol-Hematology ( Site 0567), Istanbul
Vehbi Koc Vakfi - Amerikan Hastanesi ( Site 0562), Istanbul
Universitätsklinikum Marburg ( Site 0333), Marburg
Ege University Medicine of Faculty ( Site 0565), Bornova
Dokuz Eylül Üniversitesi-Hematology ( Site 0563), Izmir
Hospital Universitario de Salamanca-Hematology ( Site 0441), Salamanca
"Policlinico S. Orsola- Malpighi-Istituto di Ematologia L. e A. Seragnoli ( Site 0381)", Bologna
Universitaetsklinikum Essen ( Site 0327), Essen
Henry Ford Hospital ( Site 0003), Detroit
Universitaetsklinikum Koeln-Klinik I für Innere Medizin ( Site 0321), Cologne
MEDICAL COLLEGE OF WISCONSIN ( Site 0016), Milwaukee
Klinikum Mutterhaus der Borromäerinnen-Innere Medizin I ( Site 0325), Trier
Ondokuz Mayıs Universitesi ( Site 0564), Samsun
University of Chicago Medical Center ( Site 0005), Chicago
Sourasky Medical Center ( Site 0525), Tel Aviv
centre hospitalier lyon sud-Service Hématologie ( Site 0300), Pierre-Bénite
Pitie Salpetriere University Hospital-Clinical haematology ( Site 0304), Paris
University of Texas MD Anderson Cancer Center ( Site 0014), Houston
Institute of Transfusion Medicine and Blood of the National Academy of Medical Sciences of Ukraine (, Lviv
University of Colorado Anschutz Medical Campus-The Center for Cancer and Blood Disorders ( Site 0021, Aurora
Chang Gung Memorial Hospital at Kaohsiung ( Site 0263), Kaohsiung Niao Sung Dist
City of Hope Comprehensive Cancer Center-Hematology ( Site 0024), Duarte
Gustave Roussy-DITEP ( Site 0301), Villejuif
Medical Oncology Associates, PS ( Site 0001), Spokane
Moscow City Clinical Hospital S.P. Botkin ( Site 0547), Moscow
Russian Scientific Research Institute of Hematology and Blood Transfusion-Hematology ( Site 0542), Saint Petersburg
Almazov National Medical Research Centre-Intensive care unit No. 10 for oncohematological patients (, Saint Petersburg
GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 0548), Ufa
Rambam Health Care Campus ( Site 0526), Haifa
Sheba Medical Center-Hemato Oncology ( Site 0524), Ramat Gan
FALP-UIDO ( Site 0623), Santiago
Instituto Nacional del Cancer ( Site 0626), Chile
Soroka Medical Center-Hematology Department ( Site 0523), Beersheba
Hadassah Medical Center ( Site 0522), Jerusalem
Instituto do Câncer e Transplante de Curitiba ( Site 0611), Curitiba
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0004), Hackensack
Rutgers Cancer Institute of New Jersey ( Site 0023), New Brunswick
Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 0601), Natal
BC Cancer Vancouver ( Site 0034), Vancouver
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0031), Toronto
Jewish General Hospital ( Site 0032), Montreal
McGill University Health Centre ( Site 0037), Montreal
Universitätsklinikum Leipzig ( Site 0328), Leipzig
Fondazione Policlinico Universitario Agostino Gemelli-ISTITUTO DI EMATOLOGIA ( Site 0383), Rome
Uniwersytecki Szpital Kliniczny-Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku ( Site, Wrocaw
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( S, Warsaw
Uniwersyteckie Centrum Kliniczne-Klinika Hematologii i Transplantologii ( Site 0424), Gdansk
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 0427), Gliwice
Instituto Catalan de Oncologia - Hospital Duran i Reynals-Haematology Department ( Site 0442), L'Hospitalet Del Llobregat
Ankara University Hospital Cebeci ( Site 0561), Ankara
National Cancer Institute ( Site 0585), Kyiv
National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine (, Kyiv
Merck Sharp & Dohme LLC
INDUSTRY